Live Quote · NASDAQINABHealthcare· Biotechnology

IN8bio, Inc.

$0.76▼ 1.86%($-0.01)
MKT CAP $8.19MNEXT EARNINGS Mar 11, 2027
50%
Bullish
TickerSpark Score
59/100
▌ Mixed
100
Valuation
20
Profitability
60
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a INAB research report →

Analyst Price Target
$4.00+427.7% vs. today

Range $4 – $4

Analyst RatingBuy
3 Buy1 Hold0 Sell

Price Chart

-52.33% · this period
$2.59$1.67$0.76Nov 20May 26Nov 20
52-Week Range2% of range
Low
$0.72
Current
$0.76
High
$2.73